Becton, Dickinson Aktie 912061 / US0758871091
228.13
USD
1.27
USD
0.56%
26.12.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Becton, Dickinson Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2024 | Becton, Dickinson & Co. (BD) | 1.58 | 3.80 | USD |
| 2023 | Becton, Dickinson & Co. (BD) | 1.41 | 3.64 | USD |
| 2022 | Becton, Dickinson & Co. (BD) | 1.56 | 3.48 | USD |
| 2021 | Becton, Dickinson & Co. (BD) | 1.35 | 3.32 | USD |
| 2020 | Becton, Dickinson & Co. (BD) | 1.36 | 3.16 | USD |
| 2019 | Becton, Dickinson & Co. (BD) | 1.22 | 3.08 | USD |
| 2018 | Becton, Dickinson & Co. (BD) | 1.15 | 3.00 | USD |
| 2017 | Becton, Dickinson & Co. (BD) | 1.49 | 2.92 | USD |
| 2016 | Becton, Dickinson & Co. (BD) | 1.47 | 2.64 | USD |
| 2015 | Becton, Dickinson & Co. (BD) | 1.81 | 2.40 | USD |
Gewinn je Aktie- Becton, Dickinson
| 5.9 24 | 4.9 23 | 5.9 22 | 6.8 21 | 2.7 20 | 3.9 19 | 0.6 18 |
Umsatz je Aktie- Becton, Dickinson
| 69.3 24 | 67.2 23 | 65.7 22 | 69.3 21 | 60.6 20 | 62.9 19 | 60.4 18 |
KGV- Becton, Dickinson
| 41.2 24 | 52.4 23 | 37.9 22 | 35.9 21 | 85.7 20 | 64.2 19 | 435 18 |
Becton, Dickinson & Co. (BD): Die Aktie (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 5.86 | 4.94 | 5.88 | 6.85 | 2.71 | 3.94 | 0.60 |
| Gewinn je Aktie unverwässert | 5.88 | 4.97 | 5.93 | 6.92 | 2.75 | 4.01 | 0.62 |
| Gewinn je Aktie verwässert | 5.86 | 4.94 | 5.88 | 6.85 | 2.72 | 3.94 | 0.60 |
| Dividende pro Aktie | 3.80 | 3.64 | 3.48 | 3.32 | 3.16 | 3.08 | 3.00 |
| Gesamtdividendenausschüttung in Mio. | 1’100.00 | 1’114.00 | 1’082.00 | 1’048.00 | 1’026.00 | 984.00 | 927.00 |
Becton, Dickinson & Co. (BD): Unternehmenskennzahlen (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 69.34 | 67.17 | 65.67 | 69.32 | 60.61 | 62.92 | 60.40 |
| KGV (Jahresendkurs, EPS unverwässert) | 41.15 | 52.36 | 37.91 | 35.86 | 85.67 | 64.20 | 435.00 |
| KGV (Jahresendkurs, EPS verwässert) | 41.15 | 52.36 | 37.91 | 35.86 | 85.67 | 64.20 | 435.00 |
| KGV (Jahresendkurs) | 41.15 | 52.36 | 37.91 | 35.86 | 85.67 | 64.20 | 435.00 |
| Dividendenrendite Jahresende in % | 1.58 | 1.41 | 1.56 | 1.35 | 1.36 | 1.22 | 1.15 |
| Eigenkapitalquote in % | 45.19 | 48.88 | 47.76 | 43.96 | 44.00 | 40.72 | 38.95 |
| Fremdkapitalquote in % | 54.81 | 51.12 | 52.24 | 56.04 | 56.00 | 59.28 | 61.05 |
Becton, Dickinson & Co. (BD): GuV (in Mio. USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 20’178.00 | 19’372.00 | 18’870.00 | 20’248.00 | 17’117.00 | 17’290.00 | 15’983.00 |
| Umsatzveränderung in % | 4.16 | 2.66 | -6.81 | 18.29 | -1.00 | 8.18 | 32.17 |
| Bruttoergebnis vom Umsatz | 9’125.00 | 8’170.00 | 8’477.00 | 9’476.00 | 7’577.00 | 8’288.00 | 7’262.00 |
| Bruttoergebnisveränderung in % | 11.69 | -3.62 | -10.54 | 25.06 | -8.58 | 14.13 | 22.21 |
| Operatives Ergebnis | 3’087.00 | 2’196.00 | 2’516.00 | 3’270.00 | 2’156.00 | 2’894.00 | 2’241.00 |
| Veränderung Operatives Ergebnis in % | 40.57 | -12.72 | -23.06 | 51.67 | -25.50 | 29.14 | 3.32 |
| Ergebnis vor Steuern | 2’005.00 | 1’662.00 | 1’783.00 | 2’242.00 | 985.00 | 1’176.00 | 1’173.00 |
| Veränderung Ergebnis vor Steuern in % | 20.64 | -6.79 | -20.47 | 127.61 | -16.24 | 0.26 | 20.18 |
| Ergebnis nach Steuer | 1’705.00 | 1’530.00 | 1’635.00 | 2’092.00 | 874.00 | 1’234.00 | 311.00 |
| Veränderung Ergebnis nach Steuer in % | 11.44 | -6.42 | -21.85 | 139.36 | -29.17 | 296.78 | -71.73 |
Becton, Dickinson & Co. (BD): Bilanz (in Mio. USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 31’396 | 26’983 | 27’652 | 30’189 | 30’247 | 30’684 | 32’910 |
| Langzeit Gesamtverbindlichk. pro Aktie | 77.62 | 70.05 | 70.02 | 82.83 | 84.17 | 92.55 | 95.79 |
| Eigenkapital | 25’890 | 25’797 | 25’282 | 23’677 | 23’765 | 21’081 | 20’994 |
| Veränderung Eigenkapital in % | 0.36 | 2.05 | 6.78 | -0.37 | 12.73 | 0.41 | 62.15 |
| Bilanzsumme | 57’286 | 52’780 | 52’934 | 53’866 | 54’012 | 51’765 | 53’904 |
| Veränderung Bilanzsumme in % | 8.54 | -0.29 | -1.73 | -0.27 | 4.34 | -3.97 | 42.85 |
Becton, Dickinson & Co. (BD): Sonstige Angaben (in USD)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 5.88 | 4.97 | 5.93 | 6.92 | 2.75 | 4.01 | 0.62 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 18.29 | -16.07 | -14.37 | 151.71 | -31.44 | 546.77 | -86.81 |
| Gewinn je Aktie (verwässert) | 5.86 | 4.94 | 5.88 | 6.85 | 2.72 | 3.94 | 0.60 |
| Veränderung Gewinn je Aktie (verwässert) in % | 18.66 | -15.99 | -14.25 | 152.36 | -31.07 | 556.67 | -86.98 |
| Anzahl Mitarbeiter | 74’000 | 73’000 | 77’000 | 75’000 | 72’000 | 70’093 | 76’032 |
| Veränderung Anzahl Mitarbeiter in % | 1.37 | -5.19 | 2.67 | 4.17 | 2.72 | -7.81 | 81.32 |
Becton, Dickinson & Co. (BD) Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Becton, Dickinson & Co. (BD) | Hauptversammlung | 28.01.2025 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 06.02.2025 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 01.05.2025 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 31.07.2025 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 06.11.2025 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 29.01.2026 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 30.04.2026 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 30.07.2026 |
| Becton, Dickinson & Co. (BD) | Quartalszahlen | 05.11.2026 |
Becton, Dickinson & Co. (BD) vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q4 2024 Earnings Release | 07.11.2024 |
| Quartalszahlen | Q3 2024 Earnings Release | 01.08.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 02.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 01.02.2024 |
| Hauptversammlung | Annual General Meeting | 23.01.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 09.11.2023 |
| Quartalszahlen | Q3 2023 Earnings Release | 03.08.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 04.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 02.02.2023 |
| Hauptversammlung | Annual General Meeting | 24.01.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 10.11.2022 |
| Quartalszahlen | Q3 2022 Earnings Release | 04.08.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 05.05.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 03.02.2022 |
| Hauptversammlung | Annual General Meeting | 25.01.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.83 |
| The Vanguard Group, Inc. | 9.04 |
| Vanguard Group, Inc. (Subfiler) | 8.74 |
| State Street Corp. | 4.83 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 4.53 |
| T. Rowe Price Associates, Inc. (IM) | 3.59 |
| Vanguard Total Stock Market ETF | 3.16 |
| T. Rowe Price Investment Management, Inc. | 3.08 |
| BlackRock Fund Advisors | 2.87 |
| Vanguard 500 Index Fund | 2.65 |
| BlackRock Institutional Trust Co. NA | 2.18 |
| Geode Capital Management LLC | 2.17 |
| Morgan Stanley Investment Management Ltd. | 2.08 |
| Generation Investment Management LLP | 2.06 |
| T Rowe Price Capital Appreciation Fund | 2.04 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 76’032 | 70’093 | 72’000 | 75’000 | 77’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.21 | 0.25 | 0.24 | 0.27 | 0.25 |
Bilanz (in Mio. USD) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 7’411 | 6’664 | 8’969 | 8’838 | 8’141 |
| Summe Anlagevermögen | 46’493 | 45’101 | 45’043 | 45’028 | 44’793 |
| Summe Aktiva | 53’904 | 51’765 | 54’012 | 53’866 | 52’934 |
Bilanz (in Mio. USD) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 32’910 | 30’684 | 30’247 | 30’189 | 27’652 |
| Summe Eigenkapital | 20’994 | 21’081 | 23’765 | 23’677 | 25’282 |
| Summe Passiva | 53’904 | 51’765 | 54’012 | 53’866 | 52’934 |
Adresse
| 1 Becton Drive, 07417-1880 Franklin Lakes | |
| Telefon | +1 (201) 847-6800 |
| URL | http://www.bd.com |
Management
|
Ami E. Simunovich
Chief Quality & Regulatory Officer, Executive VP |
|
Antoine Ezell
Chief Marketing Officer & EVP-North America |
|
Antoinette F. Segreto
Senior Vice President-Taxes |
|
Bertram L. Scott
Lead Independent Director |
|
Brooke Story
President-Integrated Diagnostic Solutions |
|
Carrie L. Byington
Independent Director |
|
Catherine M. Burzik
Independent Director |
|
Christopher Ian Montague Jones
Independent Director |
|
Christopher J. DelOrefice
Chief Financial & Accounting Officer, EVP |
|
Claire M. Fraser-Liggett
Independent Director |
|
Claudia Curtis
Chief Ethics & Compliance Officer, Senior VP |
|
David Shan
Chief Quality Officer & Executive Vice President |
|
Denise Russell Fleming
Chief Information Officer & EVP-Technology |
|
Ebonee Lewis
Chief Employment Counsel |
|
Elizabeth McCombs
Chief Technology Officer & Executive VP |
|
Gary Michael DeFazio
Secretary, Senior VP & Associate General Counsel |
|
Gregory Rodetis
Treasurer, Senior VP & Head-Investor Relations |
|
Jeffrey William Henderson
Independent Director |
|
Joanne Waldstreicher
Independent Director |
|
Joseph M. Smith
Chief Scientific Officer & Senior Vice President |
|
Michael D. Garrison
Executive VP & President-Medical Segment |
|
Michael Feld
Executive Vice President & President-Life Sciences |
|
Michelle Quinn
Executive Vice President & General Counsel |
|
Richard E. Byrd
Executive VP & President-Interventional Segment |
|
Rishi Grover
Chief Integrated Supply Chain Officer & EVP |
|
Robert Andrew Eckert
Independent Director |
|
Ronald P. Silverman
Chief Medical Officer & Executive Vice President |
|
Shana Carol Neal
Chief People Officer & Executive Vice President |
|
Stephen O. Richard
Chief Risk Officer & Senior Vice President |
|
Thomas E. Polen
Chairman, President & Chief Executive Officer |
|
Thomas J. Spoerel
Senior Vice President & Controller |
|
Timothy M. Ring
Independent Director |
|
Vishy Kanda
Chief Strategy Officer & Senior Vice President |
|
William M. Brown
Independent Director |